NCT02227290 - Pediatric Subjects With Tinea Corporis | Biotech Hunter

Enrollment

230

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

November 30, 2015

Study Completion Date

December 31, 2015

Conditions

Tinea Corporis

Interventions

DRUG

Naftin Cream

DRUG

Placebo Cream

Trial Locations (19)

27104

Merz Investigative Site#001293, Winston-Salem

27612

Merz Investigative Site#001126, Raleigh

33027

Merz Investigative Site #001310, Miramar

33144

Merz Investigative Site#001312, Miami

33175

Merz Investigative Site#001311, Miami

37215

Merz Investigative Site#001097, Nashville

64506

Merz Investigative Site#001307, Saint Joseph

68114

Merz Investigative Site#001309, Omaha

85712

Merz Investigative Site#001316, Tucson

89074

Merz Investigative Site#001314, Henderson

91436

Investigative Site# 0010320, Encino

92102

Merz Investigative Site#001301, San Diego

94538

Merz Investigative Site#001313, Fremont

97030

Investigative Site# 0010319, Gresham

Unknown

Merz Investigative Site#180002, San Cristóbal

Merz Investigative Site# 180001, Santo Domingo

Merz Investigative Site#504001, San Pedro Sula

Merz Investigative Site#507001, Panama City

00739

Merz Investigative Site#001279, Cidra

All Listed Sponsors

lead

Merz North America, Inc.

INDUSTRY